CN1247720A - Herbal products used as tobacco substitutes and methods for quitting smoking - Google Patents
Herbal products used as tobacco substitutes and methods for quitting smoking Download PDFInfo
- Publication number
- CN1247720A CN1247720A CN 98117790 CN98117790A CN1247720A CN 1247720 A CN1247720 A CN 1247720A CN 98117790 CN98117790 CN 98117790 CN 98117790 A CN98117790 A CN 98117790A CN 1247720 A CN1247720 A CN 1247720A
- Authority
- CN
- China
- Prior art keywords
- tobacco
- smoking
- herbal
- present
- nicotine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000391 smoking effect Effects 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims description 33
- 241000208125 Nicotiana Species 0.000 title 1
- 235000019505 tobacco product Nutrition 0.000 claims abstract description 20
- 244000061176 Nicotiana tabacum Species 0.000 claims description 32
- 235000008216 herbs Nutrition 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 9
- 240000005385 Jasminum sambac Species 0.000 claims description 9
- 240000004371 Panax ginseng Species 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 239000001585 thymus vulgaris Substances 0.000 claims description 9
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 8
- 238000000222 aromatherapy Methods 0.000 claims description 8
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 7
- 229940010454 licorice Drugs 0.000 claims description 7
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 6
- 244000178870 Lavandula angustifolia Species 0.000 claims description 6
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 6
- 240000002657 Thymus vulgaris Species 0.000 claims description 6
- 235000017803 cinnamon Nutrition 0.000 claims description 6
- 239000001102 lavandula vera Substances 0.000 claims description 6
- 235000018219 lavender Nutrition 0.000 claims description 6
- 240000008415 Lactuca sativa Species 0.000 claims description 5
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 5
- 240000003538 Chamaemelum nobile Species 0.000 claims description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 4
- 244000061508 Eriobotrya japonica Species 0.000 claims description 4
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 4
- 244000194101 Ginkgo biloba Species 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 4
- 244000223014 Syzygium aromaticum Species 0.000 claims description 4
- 235000010730 Ulex europaeus Nutrition 0.000 claims description 4
- 240000003864 Ulex europaeus Species 0.000 claims description 4
- 230000005586 smoking cessation Effects 0.000 claims description 4
- 241000208140 Acer Species 0.000 claims description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 3
- 240000006891 Artemisia vulgaris Species 0.000 claims description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 3
- 241000335053 Beta vulgaris Species 0.000 claims description 3
- 108010009685 Cholinergic Receptors Proteins 0.000 claims description 3
- 244000004281 Eucalyptus maculata Species 0.000 claims description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 3
- 102000034337 acetylcholine receptors Human genes 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract 1
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract 1
- 229960002715 nicotine Drugs 0.000 description 20
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 20
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 19
- 235000019504 cigarettes Nutrition 0.000 description 16
- 239000000779 smoke Substances 0.000 description 15
- 239000002398 materia medica Substances 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 235000019506 cigar Nutrition 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 244000246386 Mentha pulegium Species 0.000 description 4
- 235000016257 Mentha pulegium Nutrition 0.000 description 4
- 235000004357 Mentha x piperita Nutrition 0.000 description 4
- 235000001050 hortel pimenta Nutrition 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 244000166124 Eucalyptus globulus Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 241000246358 Thymus Species 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- -1 pleasure Chemical compound 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 2
- 235000002657 Artemisia tridentata Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 235000019568 aromas Nutrition 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000019788 craving Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001779 taste bud Anatomy 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 210000001691 amnion Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 235000019558 anosmia Nutrition 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002609 anti-worm Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 231100000502 fertility decrease Toxicity 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000022119 inability to concentrate Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003715 limbic system Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 238000002670 nicotine replacement therapy Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000002254 stillbirth Diseases 0.000 description 1
- 231100000537 stillbirth Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本发明涉及一种本草产品、其用途,及一种戒断烟草吸食的方法。本发明的本草产品可做为烟草产品的替代品,有助于吸烟的戒断,并提供营养性及生理性有益功效。The invention relates to a herbal product, its use, and a method for quitting tobacco smoking. The herbal product of the present invention can be used as a substitute for tobacco products, helps smoking cessation, and provides nutritional and physiological beneficial effects.
烟草的吸食一直为现今社会中对公众健康的最大威胁。业为人所熟知者,烟草的吸食,主要由于尼古丁的摄入,无可争议地造成肺部疾病,特别是肺癌,且显著提高发生心脏血管疾病的危险性,包括冠状动脉心脏疾病、中风、猝死、主动脉瘤及周边血管疾病。据报导,烟草的吸食造成全世界每年超过三百万人口的死亡(R.Peto等人,Br.Med.Bull,52:12-21(1996))。Tobacco smoking remains the greatest threat to public health in today's society. It is well known that tobacco smoking, mainly due to nicotine intake, is indisputably responsible for lung disease, especially lung cancer, and significantly increases the risk of cardiovascular disease, including coronary heart disease, stroke, sudden death , aortic aneurysm and peripheral vascular disease. Tobacco smoking is reported to be responsible for over three million deaths per year worldwide (R. Peto et al., Br. Med. Bull, 52: 12-21 (1996)).
吸食烟草所可能造成的其他健康危险包括胃溃疡、白内障及妇女受精率降低与骨质疏松。此外,业经确认,烟草对妊娠有害,其作用包括流产、死产、自发性流产、出血及羊膜早期破裂。Other possible health risks from tobacco smoking include stomach ulcers, cataracts, and reduced fertility and osteoporosis in women. In addition, tobacco has been established to be harmful to pregnancy, with effects including miscarriage, stillbirth, spontaneous miscarriage, hemorrhage, and premature rupture of the amniotic membranes.
除吸烟者本身的外,其周遭的人亦受吸烟的不良影响。环境烟害业经确认为患病率及死亡率的主要原因。因此,世界各地有反烟团体的组成,及烟害防治法规的制定。吸烟者因而除健康的危害外,尚面临极大的社会压力。In addition to the smoker himself, the people around him are also affected by the adverse effects of smoking. Environmental tobacco hazards have been identified as a major cause of morbidity and mortality. Therefore, anti-tobacco groups are formed all over the world, and regulations on smoking prevention and control are formulated. Smokers therefore face great social pressure in addition to health hazards.
仅管吸烟者知悉吸食烟草的坏处,大多人发现戒烟极其不易。造成吸烟戒断失败的原因的一为,尼古丁摄取突然中断所引起的戒断症状,其包括焦燥、易怒、失眠、无法集中精神及增重。已有建议以尼古丁取代疗法减缓前述症状,以帮助欲终止吸烟习惯的吸烟者。用于此种目的的产品包括尼古丁经皮贴、尼古丁口香糖、尼古丁鼻部喷剂及尼古丁吸入剂。此等取代疗法均经显示对吸烟戒断的有效治疗。Although smokers are aware of the dangers of smoking tobacco, most find it extremely difficult to quit. One of the causes of failure to quit smoking is the withdrawal symptoms caused by the sudden cessation of nicotine intake, which include restlessness, irritability, insomnia, inability to concentrate and weight gain. Nicotine replacement therapy has been proposed to alleviate the aforementioned symptoms to help smokers who want to stop their smoking habit. Products used for this purpose include nicotine transdermal patches, nicotine gum, nicotine nasal spray and nicotine inhalers. These replacement therapies have all been shown to be effective in the treatment of smoking cessation.
不过,已知烟草吸食者会将摄入尼古丁而产生的效果与特定情境及环境刺激产生联想,例如尼古丁产生的正面效果,如愉悦、亢奋及松驰等,及尼古丁对负面情绪的消除,如焦虑、紧迫、怒气、易怒及抑郁心情等。因此,点烟、吸烟,甚至烟嘴的咀嚼在吸食烟草所提供的满足感中占重要地位。研究显示,吸烟者吸食去尼古丁香烟,确有报告答到满足,且减轻戒断症状者。However, tobacco smokers are known to associate the effects of nicotine intake with specific situations and environmental stimuli, such as the positive effects of nicotine, such as pleasure, excitement, and relaxation, and the elimination of negative emotions, such as Anxiety, urgency, anger, irritability, and depression. Thus, lighting, smoking, and even chewing of the mouthpiece feature heavily in the satisfaction that smoking tobacco provides. Studies have shown that smokers who smoke nicotine-free cigarettes do report satisfaction and relieve withdrawal symptoms.
嗅觉的刺激与其他感官的刺激不同。该刺激不须经由大脑皮质,而是直接作用在边缘系。因此,嗅觉刺激可不经理性判断而直接刺激情绪反应。嗅觉丧失的病患会有味觉障碍及食欲不振的并发症,此外,其亦较压抑、内向,且易丧失记忆。Stimulation of smell is different from stimulation of other senses. The stimulation does not have to go through the cerebral cortex, but acts directly on the limbic system. Thus, olfactory stimuli can directly stimulate emotional responses without rational judgment. Patients with anosmia have complications of taste disturbance and loss of appetite. In addition, they are more depressed, withdrawn, and prone to memory loss.
芳香疗法在近年越来越盛行。然而,香味已被用于不同用途达千年以上。例如,中国传统医药即知燃烧本草以治疗疾病或强化生理机能。中国人自古即藉檀香的薰烧来达到镇定及抗抑制的效果,并利用迷迭香麻醉。Aromatherapy has become more and more popular in recent years. However, scents have been used for different purposes for thousands of years. For example, traditional Chinese medicine knows to burn herbs to treat diseases or enhance physiological functions. Since ancient times, the Chinese have used the fumigation of sandalwood to achieve calming and anti-inhibitory effects, and used rosemary for anesthesia.
同样地,西方人则由本草植物的花、叶、树皮及/或种子萃取精油。咸信吸入精油释出(有时藉助薰烧)的香味及/或分子具有治疗价值,例如可减轻心理压力、情绪压力、生理压力及环境压力。此外,精油亦被用作按摩油或浴油,以达调理、美容及/或放松的功效。Likewise, Westerners extract essential oils from the flowers, leaves, bark and/or seeds of herbal plants. The aromas and/or molecules released by inhalation (sometimes by fumigation) of essential oils are believed to have therapeutic value, such as reducing psychological, emotional, physical and environmental stress. In addition, essential oils are used as massage or bath oils for conditioning, beauty and/or relaxation.
用于芳香疗法之本草的药学有益功效及其所含产生该等功效的活性成份业经研究确认。请参阅例如N.Paster等人,J.of Food Protection,58(1):81-85(1994);Research Review,HerbalGram No.39.19;ResearchReview,HerbalGram No.39.21;A.Sivropoulou等人,J.Agric.Food Chem.,43:2384-2388(1995);及K.Samejima等人,J.Agric.Food Chem.,43:4410-414(1995)。此等文献的全部内容及其相关部分兹并于本文,为本文的参考。The medicinal benefits of herbs used in aromatherapy and the active ingredients they contain to produce these effects have been confirmed by research. See, eg, N. Paster et al., J. of Food Protection, 58(1):81-85 (1994); Research Review, Herbal Gram No. 39.19; Research Review, Herbal Gram No. 39.21; A. Sivropoulou et al., J. Agric. Food Chem., 43: 2384-2388 (1995); and K. Samejima et al., J. Agric. Food Chem., 43: 4410-414 (1995). The entire contents of these documents and relevant parts thereof are hereby incorporated herein by reference.
尽管如此,尚未有建议将芳香疗法用于烟草的替代及戒断者。Despite this, there have been no recommendations for the use of aromatherapy in tobacco substitutes and abstainers.
阿耳茨海默氏病(Alzheimer’s Disease,AD)是一种慢性症状出现严重神经变性的进行性早老化精神病症,易迅速演进成痴呆症,病患的认知及智力功能深受破坏,是成人阶段痴呆的最主要原因。据统计,美加地区目前约有贰佰伍拾万人患AD。随着老化人口的渐增,AD对大众健康的冲击将持续增加是可预期的,因此,研发AD的有效治疗剂乃刻不容缓之事。Alzheimer's disease (Alzheimer's Disease, AD) is a progressive premature aging psychiatric disorder with chronic symptoms and severe neurodegeneration. It is easy to rapidly evolve into dementia. Leading cause of dementia in adulthood. According to statistics, there are currently about 2.5 million people suffering from AD in the US and Canada. With the increasing aging population, it is expected that the impact of AD on public health will continue to increase. Therefore, it is urgent to develop effective therapeutic agents for AD.
报告指出,AD患者脑部神经传导物质的产生有减少现象,特别是乙酰胆碱及受体。因此,咸信可增加该等受体产量的药剂对AD的治疗有效。The report pointed out that the production of neurotransmitters in the brain of AD patients has decreased, especially acetylcholine and receptors. Therefore, agents that increase the production of these receptors are believed to be effective in the treatment of AD.
本发明的目的是一种不含尼古丁的烟草产品替代品。The object of the present invention is a nicotine-free substitute for tobacco products.
本发明的另一目的是提供一种可帮助烟草吸食者戒烟的不含尼古丁产品。Another object of the present invention is to provide a nicotine-free product that can help tobacco smokers quit smoking.
本发明的再一目的是提供可对烟草吸食者产生有利功效的不含尼古丁产品。Yet another object of the present invention is to provide nicotine-free products that have beneficial effects on tobacco smokers.
本发明的又一目的是提供一种戒断烟草吸食的方法。Yet another object of the present invention is to provide a method for quitting tobacco smoking.
意外地,本发明的目的可藉由使用常规用于芳香疗法的本草或本草混合物取代烟草相关产品中的烟草而达成。Surprisingly, the object of the present invention can be achieved by replacing tobacco in tobacco-related products with herbs or mixtures of herbs conventionally used in aromatherapy.
因此,本发明提供一种本草产品,其含有常规用于芳香疗法的本草或本草混合物。本发明的本草产品不含尼古丁,因此适于做为烟草产品的替代品。Accordingly, the present invention provides a herbal product comprising herbs or mixtures of herbs conventionally used in aromatherapy. The herbal product of the invention does not contain nicotine, so it is suitable as a substitute for tobacco products.
本文所称“烟草产品”或“传统烟草产品”是指任何用以经由燃烧而吸食的烟草植物传统制品。此等制品的实例包括但不限于一般香烟及去尼古丁香烟、雪茄、烟丝及类似物。因此,本文所称“烟草产品替代品”是指用以取代烟草吸食者惯常吸食的一般香烟及去尼古丁香烟、雪茄及烟丝与类似物的产品。As used herein, "tobacco product" or "traditional tobacco product" refers to any traditional product of the tobacco plant intended to be smoked by combustion. Examples of such articles include, but are not limited to, regular cigarettes and nicotine-reduced cigarettes, cigars, shredded tobacco, and the like. Therefore, the term "tobacco product substitutes" herein refers to products used to replace regular cigarettes and nicotine-removed cigarettes, cigars, shredded tobacco and the like that are used by tobacco smokers.
任何常规用于芳香疗法的本草种类均适用于本发明。此等本草的实例包括但不限于丁香、金雀花、甘草、茉莉花、枫、银杏、莴苣、甜菜、枇杷、茶、人参、洋甘菊、肉桂、薄荷、山艾、百里香、迷失香、薰衣草、桉及类似者。本发明本草产品可使用单一的本草种类或不同本草的混合物。本草混合物的实例包括但不限于:Any herbal species conventionally used in aromatherapy are suitable for use in the present invention. Examples of such herbs include, but are not limited to, clove, gorse, licorice, jasmine, maple, ginkgo, lettuce, beet, loquat, tea, ginseng, chamomile, cinnamon, peppermint, sagebrush, thyme, striata, lavender, eucalyptus and the like. The herbal product of the present invention can use a single herbal species or a mixture of different herbal medicines. Examples of herbal blends include, but are not limited to:
本草 % 本草 %Materia Medica % Materia Medica %
丁香 10-20 人参叶 5-10Clove 10-20 Ginseng Leaf 5-10
金雀花 10-20 茉莉 10-20Gorse 10-20 Jasmine 10-20
甘草 5-10 甘草 10-20Licorice 5-10 Licorice 10-20
茉莉 10-20 甜茶 5-10Jasmine 10-20 Sweet Tea 5-10
银杏 5-10 枇杷 5-10Ginkgo 5-10 Loquat 5-10
莴苣 10-20 茶 5-10Lettuce 10-20 Tea 5-10
人参叶 5-10 洋甘菊 10-20Ginseng leaves 5-10 Chamomile 10-20
薄荷 20-30Peppermint 20-30
本草 % 本草 %Materia Medica % Materia Medica %
肉桂 10-20 银杏 5-10Cinnamon 10-20 Ginkgo 5-10
百里香 10-20 枫 10-20Thyme 10-20 Maple 10-20
迷迭香 5-10 莴苣 10-20Rosemary 5-10 Lettuce 10-20
薰衣草 5-10 甜菜 5-10Lavender 5-10 Beet 5-10
桉 5-10 百里香 10-20Eucalyptus 5-10 Thyme 10-20
薄荷 5-10 迷迭香 10-20Mint 5-10 Rosemary 10-20
人参 10-20 薰衣草 5-10Ginseng 10-20 Lavender 5-10
茉莉 10-20Jasmine 10-20
本草 % 本草 %Materia Medica % Materia Medica %
甘草 5-10 百里香 10-20Licorice 5-10 Thyme 10-20
肉桂 10-20 迷迭香 10-20Cinnamon 10-20 Rosemary 10-20
山艾 5-10 枇杷 10-20Sagebrush 5-10 Loquat 10-20
百里香 10-20 人参 10-20Thyme 10-20 Ginseng 10-20
迷迭香 10-20 莴苣 10-20Rosemary 10-20 Lettuce 10-20
桉 5-10 茉莉 5-10Eucalyptus 5-10 Jasmine 5-10
人参 5-10 甘草 5-10Ginseng 5-10 Licorice 5-10
金雀花 10-20Gorse 10-20
本发明本草产品可使用传统方法制造。大体而言,是于干燥整株植物或其部分后将其切碎及/或切丝,或者可于切碎和/或切丝后再干燥。适用的本草部分包括但不限于花、果、茎、叶及类似部分。其后,将经干燥、切碎和/或切丝的本草调味,再以传统方法烘烤。然后,若需制造香烟或雪茄,则将切碎和/或切丝的本草包入可燃性包覆层的管腔中,制成管状产品。The herbal product of the present invention can be manufactured using traditional methods. In general, the whole plant or parts thereof are chopped and/or shredded after drying, or may be chopped and/or shredded and then dried. Suitable parts of herbal medicines include, but are not limited to, flowers, fruits, stems, leaves and the like. The dried, chopped and/or julienned herbs are then seasoned and roasted in the traditional way. Then, if cigarettes or cigars are to be manufactured, the shredded and/or shredded herb is wrapped in the lumen of the combustible wrap to create a tubular product.
本发明可便利地使用传统用于包卷香烟的可燃性包覆层,例如木浆制纸。然而,亦可使用由他种天然纤维制成的可燃性包覆层,例如亚麻所制者。此外,为降低传统包覆纸中添加物造成的副作用,例如重金属及萤光剂,可使用未经漂白处理的包覆纸。若需制造雪茄替代品,则所用包覆层需仿造传统雪茄的外观。The present invention advantageously utilizes combustible wraps traditionally used to wrap cigarettes, such as wood pulp paper. However, combustible coverings made of other natural fibres, such as flax, may also be used. In addition, in order to reduce the side effects caused by additives in traditional covering paper, such as heavy metals and fluorescent agents, unbleached covering paper can be used. To create a cigar substitute, the wrapping used needs to mimic the look of a traditional cigar.
为增加消费者接受性,本发明本草产品可参照传统烟草产品,调制成具浓烟、一般烟、淡烟及凉烟等选择。此外,本发明本草产品可添加香料,以仿效商业成功的烟草品牌。In order to increase consumer acceptance, the herbal products of the present invention can be prepared with reference to traditional tobacco products, such as thick smoke, normal smoke, light smoke and cold smoke. In addition, the herbal products of the present invention may be flavored to emulate commercially successful tobacco brands.
为达增进的效果,可将萃取精油加至含味道不同的本草或本草混合物的本发明本草产品中。For enhanced effect, the extracted essential oils may be added to the herbal products of the present invention which contain herbs or mixtures of herbs with different flavors.
虽不欲为理论所限,咸信燃烧本发明本草产品所释出的烟或其中所含分子,可为鼻粘膜或口腔粘膜吸收,并迅速与神经系统的尼古丁亲和性受体结合。与尼古丁受体的结合可产生吸食尼古丁的正面生理反应,但不产生相关的副作用。Although not intending to be bound by theory, it is believed that the smoke released by burning the herbal product of the present invention or the molecules contained therein can be absorbed by the nasal or oral mucosa and quickly bind to the nicotine affinity receptors of the nervous system. Binding to nicotine receptors produces the positive physiological response of nicotine ingestion without the associated side effects.
因此,本发明提供一种戒断烟草吸食的方法,其包括使燃烧本草或本草混合物所释出的物质与乙酰胆碱受体结合。Accordingly, the present invention provides a method of cessation of tobacco smoking which comprises binding substances released from burning a herb or mixture of herbs to acetylcholine receptors.
此外,点烟、吸食及/或烟嘴咀嚼的动作联同鼻部及口腔粘膜的刺激,可满足烟草吸食者对于烟草吸食的心理依赖性。因此,本发明本草产品可作为想继续抽烟但不危害健康的吸烟者的烟草产品替代品。In addition, the actions of lighting, smoking and/or mouth chewing together with the stimulation of nasal and oral mucosa can satisfy tobacco smokers' psychological dependence on tobacco smoking. Therefore, the herbal product of the present invention can be used as a tobacco product substitute for smokers who want to continue smoking without endangering their health.
传统烟草产品吸食者吸食本发明本草产品一段时间后,将产生尼古丁排斥反应。虽不欲为理论所限,咸信该现象是因缺乏尼古丁的刺激造成原本对尼古丁具亲和性的受体渐渐衰退,终至消失的故。此外,亦相信烟草吸食者舌头上的味蕾在吸食本发明产品后显著地回复原有的敏感性,而功能良好的味蕾使吸烟者对烟草的臭味产生排斥。Smokers of traditional tobacco products will produce nicotine rejection reaction after smoking the herbal product of the present invention for a period of time. Although not intending to be limited by theory, it is believed that this phenomenon is due to the lack of nicotine stimulation, which causes the receptors with affinity to nicotine to gradually decline and eventually disappear. In addition, it is also believed that the taste buds on the tongues of tobacco smokers remarkably restore their original sensitivity after smoking the product of the present invention, and that the taste buds with good function make the smokers repel the smell of tobacco.
因此,本发明本草产品进一步可帮助想永远停止吸烟的烟草产品吸食者停止吸烟,而不产生戒断症状。Therefore, the herbal product of the present invention can further help smokers of tobacco products who want to stop smoking permanently to stop smoking without producing withdrawal symptoms.
一旦决定以本发明本草产品替代传统烟草产品或停止吸食,吸食者可立即并完全以本发明本草产品取代其一般吸食的烟草产品。或者,可采用渐渐以本发明本草产品替代传统烟草产品的渐进式方法。亦即,可在开始时使用少量本发明本草替代品取代传统产品,例如一支,然后渐渐增加每日吸食本发明替代品的数目,至吸食者习惯吸食的每日数量完全被本发明替代品所取代。此外,本发明替代品亦可与传统烟草产品交替使用。对于习惯吸食特定品牌或口味之香烟产品的瘾君子,骤然改变所吸食的烟草产品,可能造成强烈的心理排斥感,因此,以渐进式或交替式取代的方法较佳。Once deciding to use the herbal product of the present invention to replace traditional tobacco products or stop smoking, smokers can immediately and completely replace their usual tobacco products with the herbal product of the present invention. Alternatively, an incremental approach may be employed in which traditional tobacco products are gradually replaced with the herbal products of the present invention. That is to say, at the beginning, a small amount of the herbal substitute of the present invention can be used to replace the traditional product, such as one stick, and then gradually increase the number of daily intake of the substitute of the present invention until the daily quantity that the smoker is used to sucking is completely replaced by the substitute of the present invention. replaced. In addition, the substitute of the present invention can also be used alternately with traditional tobacco products. For addicts who are accustomed to smoking a specific brand or flavor of cigarette products, sudden changes in the tobacco products they smoke may cause a strong sense of psychological rejection. Therefore, it is better to use gradual or alternating replacement methods.
已知,习惯于特定品牌的吸食者,平均需120支传统香烟才可习惯一种新的品牌。欲使此种习惯吸食特定品牌或口味的瘾君子接受本发明本草替代品,所需的数量较少。It is known that smokers who are used to a particular brand need an average of 120 traditional cigarettes to get used to a new brand. To make addicts who are used to smoking specific brands or flavors accept the herbal substitute of the present invention, the required quantity is relatively small.
令人意外地,习惯吸食凉烟的瘾君子,平均于吸食约10支本发明本草替代品后,对于烟草产生排斥;习惯淡烟者则在吸食约15支本发明本草替代品后产生相同感觉;而习惯抽浓烟者,则约为5支。Surprisingly, addicts who are used to smoking cold tobacco have an average rejection of tobacco after smoking about 10 sticks of the herbal substitute of the present invention; those who are accustomed to light smoke have the same feeling after smoking about 15 sticks of the herbal substitute of the present invention ; and habitual smokers, about 5.
如果希望停止吸烟,则原本吸烟者可于不再有吸烟欲望时即停止其吸烟行为。如果于短期内又犯烟瘾,例如因生理依赖性造成的烟瘾,则可以本发明本草产品为其习惯吸食的传统于草产品的替代品。If you want to stop smoking, ex-smokers can stop smoking when they no longer have the desire to smoke. If in a short period of time there is a smoking craving again, such as a smoking craving caused by physiological dependence, the herbal product of the present invention can be used as a substitute for the traditional herbal product that is used to smoking.
因为本发明所用的本草是常规用于芳香疗法者,因此,燃烧本发明本草产品可现成地产生已知具有益功效的香味或分子。此外,所用本草本身可提供特定的养份。因此,除烟草替代及戒断功效的外,本发明本草产品尚提供营养性及生理性效果。Since the herbs used in the present invention are conventionally used in aromatherapy, burning the herbal products of the invention can readily generate aromas or molecules known to have beneficial effects. In addition, the herbs used provide specific nutrients themselves. Therefore, in addition to tobacco substitution and withdrawal effects, the herbal product of the present invention also provides nutritional and physiological effects.
明显地,本发明本草产品提供的附加效果随所用本草或本草混合物而异。下述效果仅为说明的用:洋甘菊可释出芹菜配基,具抗焦、抗忧郁、止痛、抗过敏、止痒及增强免疫的作用;甘草所含的甘草甜素可强化肝脏机能、降低胆固醇并预防动脉硬化,且可做为解毒剂、抗溃疡剂、解痉剂、消炎剂及祛痰剂;已知薄荷因所含的薄荷醇可镇痛、麻醉、消炎、抗菌、消肿、祛痰、健胃、解热及发汗;已知丁香所含的丁香油酚可镇痛、麻醉、解热、抗溃疡、驱蠕虫、抗菌、抗真菌、抗病毒、抗结核、抗气喘及治疗支气管炎;已知百里香所含的百里酚可强化肺功能、保护呼吸系统,可预防支气管炎及风湿,且可止痛及振奋精神;且茉莉所含的茉莉酮可调整情绪、镇静、止痛及平衡荷尔蒙。Obviously, the additional effects provided by the herbal products of the present invention will vary depending on the herb or mixture of herbs used. The following effects are for illustration only: Chamomile can release apigenin, which has anti-anxiety, anti-depressant, pain-relieving, anti-allergic, anti-itching and immune-enhancing effects; glycyrrhizin contained in licorice can strengthen liver function, reduce Cholesterol prevents arteriosclerosis, and can be used as antidote, anti-ulcer agent, antispasmodic, anti-inflammatory agent and expectorant; It is known that the menthol contained in peppermint can relieve pain, anesthesia, anti-inflammatory, antibacterial, detumescence, Expectorant, stomach, antipyretic and sweating; eugenol contained in cloves is known to be analgesic, anesthesia, antipyretic, anti-ulcer, anti-worm, anti-bacterial, anti-fungal, anti-viral, anti-tuberculosis, anti-asthma and treatment Bronchitis; it is known that the thymol contained in thyme can strengthen lung function, protect the respiratory system, prevent bronchitis and rheumatism, relieve pain and invigorate the spirit; and the jasmone contained in jasmine can adjust mood, calm, relieve pain and Balance hormones.
再得,咸信本发明本草产品所释出的烟(或其所含的分子)对乙酰胆碱受体的亲和性,可藉由增加脑细胞中的神经传导物质及受体而活化脑细胞,并进而改善例如AD患者的记忆及认知能力。Furthermore, it is believed that the smoke released by the herbal product of the present invention (or the molecules contained therein) has an affinity for acetylcholine receptors, which can activate brain cells by increasing neurotransmitters and receptors in brain cells, And further improve the memory and cognitive ability of AD patients, for example.
兹以下述实施例进一步说明本发明,但该等实施例非本发明的限制条件。The present invention is further illustrated by the following examples, but these examples are not limitations of the present invention.
实施例1Example 1
本草卷制品的制造
将干燥的肉桂、百里香、迷迭香、薰衣草、桉、薄荷、人参及茉莉切成适当大小。取适量的碎本草混合,得具下示组成的混合物:Chop dried cinnamon, thyme, rosemary, lavender, eucalyptus, peppermint, ginseng and jasmine to size. Take an appropriate amount of crushed herbs and mix to obtain a mixture with the following composition:
本草 %Materia Medica %
肉桂 7cinnamon 7
百里香 18Thyme 18
迷迭香 8Rosemary 8
薰衣草 7Lavender 7
桉 9Eucalyptus 9
薄荷 20Mint 20
人参 15Ginseng 15
茉莉 16Jasmine 16
经调味及烘烤定味后,以亚麻制纸包卷该混合物,得管状本草卷制品。After seasoning and baking to set the taste, wrap the mixture with flax paper to obtain a tubular herbal product.
实施例2Example 2
营养分析实施例1所制本草卷制品的营养分析如下:
实施例3Example 3
尼古丁排斥反应Nicotine rejection
受试者为平均烟龄为10年以上,且每日24小时至少吸食20支烟的瘾君子。受试者在试验前三年内至少企图戒烟两次,但在试验前均未成功。受试者依所吸食香烟的口味分成三组:传统浓烟组、淡烟组及凉烟组。试验期间,受试者依本身的自由意愿及吸烟习惯,选择吸食实施例1所制的本草卷制品及其习惯的传统香烟。受试者被要求记录当其吸食至少一支本草卷制品后重新吸食传统香烟的感觉,及其重新吸食传统香烟前所连续吸食的本草卷制品的数目。尼古丁排斥反应的定义为:受试者对其先前习惯的传统香烟的刺激、口味及味道产生不好的感觉,致使其不再有吸食香烟的欲望。The subjects were addicts with an average smoking age of more than 10 years and who smoked at least 20 cigarettes in 24 hours a day. Subjects had attempted to quit smoking at least twice in the three years prior to the trial, but were unsuccessful prior to the trial. The subjects were divided into three groups according to the taste of the cigarettes they smoked: traditional heavy smoke group, light smoke group and cold smoke group. During the test period, the subjects chose to smoke the rolled herbal products made in Example 1 and the traditional cigarettes they used to according to their own free will and smoking habits. The subjects were asked to record how they felt when they smoked at least one herbal rolled product, and the number of consecutive herbal rolled products they smoked before resuming traditional cigarettes. Nicotine rejection is defined as the unpleasant sensation, taste, and taste of a traditional cigarette to which the subject was previously accustomed, such that the subject no longer desires to smoke it.
经发现,浓烟组受试者中,80%于连续吸食约5支的本草卷制品后,开始尼古丁排斥反应;淡烟组中75%的受试者,于连续吸食约15支本草卷制品后出现相同反应;而凉烟组中约73%的受试者,于连续吸食约20支本草卷制品后出现相同反应。It was found that 80% of the subjects in the heavy smoking group began to reject nicotine after smoking about 5 herbal rolled products in a row; 75% of the subjects in the light smoking group smoked about 15 herbal rolled products in a row After smoking about 20 herbal products, about 73% of the subjects in the cold tobacco group had the same reaction.
实施例4Example 4
戒烟计划采用下示方法帮助每天20支烟的瘾君子替代或戒断烟草吸食:
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98117790 CN1247720A (en) | 1998-09-14 | 1998-09-14 | Herbal products used as tobacco substitutes and methods for quitting smoking |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98117790 CN1247720A (en) | 1998-09-14 | 1998-09-14 | Herbal products used as tobacco substitutes and methods for quitting smoking |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1247720A true CN1247720A (en) | 2000-03-22 |
Family
ID=5225709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 98117790 Pending CN1247720A (en) | 1998-09-14 | 1998-09-14 | Herbal products used as tobacco substitutes and methods for quitting smoking |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1247720A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101444332B (en) * | 2008-04-16 | 2011-08-17 | 阙汀贤 | Health care blended type cigarette |
| CN103054167A (en) * | 2013-01-15 | 2013-04-24 | 济南鼻烟研究所 | Rosemary scented snuff |
| CN104585870A (en) * | 2015-01-20 | 2015-05-06 | 川渝中烟工业有限责任公司 | Electronic cigarette tobacco liquid with functions of relieving cough and moistening lung |
| CN105686065A (en) * | 2016-03-30 | 2016-06-22 | 凌洪涛 | Tea tobacco and making method thereof |
| CN113455695A (en) * | 2021-06-30 | 2021-10-01 | 河南中烟工业有限责任公司 | Processing method of clove raw material and application of clove raw material in clove type cigarettes |
-
1998
- 1998-09-14 CN CN 98117790 patent/CN1247720A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101444332B (en) * | 2008-04-16 | 2011-08-17 | 阙汀贤 | Health care blended type cigarette |
| CN103054167A (en) * | 2013-01-15 | 2013-04-24 | 济南鼻烟研究所 | Rosemary scented snuff |
| CN104585870A (en) * | 2015-01-20 | 2015-05-06 | 川渝中烟工业有限责任公司 | Electronic cigarette tobacco liquid with functions of relieving cough and moistening lung |
| CN105686065A (en) * | 2016-03-30 | 2016-06-22 | 凌洪涛 | Tea tobacco and making method thereof |
| CN113455695A (en) * | 2021-06-30 | 2021-10-01 | 河南中烟工业有限责任公司 | Processing method of clove raw material and application of clove raw material in clove type cigarettes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100370340B1 (en) | Tobacco Substitute Composition | |
| RU72821U1 (en) | SMOKLESS SMOKING PRODUCT (OPTIONS) | |
| CN100531606C (en) | A kind of preparation method of cigarette that replaces tobacco with green tea | |
| JPH11137232A (en) | Herb product | |
| EP2941135B1 (en) | Tobacco substitute | |
| CN110367581A (en) | A composition containing cannabidiols extracted from industrial hemp and its use in tobacco products | |
| CN100506241C (en) | Smoking cessation healthcare product and preparation method thereof | |
| CN101991182B (en) | Method for producing nontoxic and harmless tobacco leaves from low-grade tea leaves, tea dust and other tea raw materials by paper making method | |
| WO2019086047A1 (en) | Agarwood cigarette additive, production method therefor, usage method therefor, and agarwood cigarette containing cigarette additive | |
| US20110038915A1 (en) | Chewing Gum Formula for Enhancing Psycho-Spirituality | |
| CN100574633C (en) | Pomegranate health inhalant and preparation method thereof | |
| CN1247720A (en) | Herbal products used as tobacco substitutes and methods for quitting smoking | |
| JP2959712B2 (en) | Non-smoking smoking article and method for producing the same | |
| KR102013417B1 (en) | Composition for herbal cigarettes and manufacturing method threrof | |
| KR19990000236A (en) | Smoking cessation combined use and preparation method thereof | |
| WO1999020131A1 (en) | A cigarette of ginkgo leaves | |
| US20120288450A1 (en) | Chewing gum formula for enhancing psycho-spirituality | |
| KR102575957B1 (en) | Cigarette using kenaf and method for manufacturing the same | |
| CN101176570A (en) | A kind of natural flavor additive for tobacco and preparation method thereof | |
| US5130132A (en) | Composition and method for treating nicotine dependency | |
| CN116268528A (en) | An improved electronic cigarette smoke liquid and its preparation method and electronic cigarette | |
| KR19990083879A (en) | Manufacturing method of product made out of chief materials of perilla frutescens in replace of smoking | |
| CN110373264A (en) | A composition containing industrial hemp essential oil for tobacco products | |
| CN1019736B (en) | Produce the method for tobacco medical additive | |
| US20220022521A1 (en) | New tobacco substitutes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication |